Abstract:Circulating bone marrow-derived endothelial progenitor cells (EPCs) seem to play a crucial role in both vasculogenesis and vascular homeostasis. Chronic kidney disease is a state of endothelial dysfunction, accelerated progression of atherosclerosis and high cardiovascular risk. As a consequence, cardiovascular disorders are the main cause of death in end-stage renal disease (ESRD). It has been shown that patients with advanced renal failure have decreased number of bone marrow-derived endothelial progenitor cells and impaired EPCs function. Moreover, in kidney transplant patients, renal graft function significantly correlated with EPC number. The reduced number of EPCs in patients with ESRD has been ascribed to the uremia. Therefore, therapies that improve the uremic status in dialysis patients such as nocturnal hemodialysis are associated with restoration of impaired EPCs number and migratory function. In fact, some of the common treatments for patients with chronic kidney disease such as erythropoietin, statins and angiotensin II receptor antagonist increase the number of EPCs. Nowadays, there is growing evidence indicating that, under pathophysiological conditions, stem cells (SCs) derived from bone marrow are able to migrate in the injured kidney, and they seem to play a role in glomerular and tubular regeneration. After acute tubular renal injury, surviving tubular epithelial cells and putative renal stem cells proliferate and differentiate into tubular epithelial cells to promote structural and functional repair. Moreover, bone marrow stem cells, including hematopoietic stem cells and mesenchymal stem cells can also participate in the repair process by proliferation and differentiation into renal lineages. For instance, mesenchymal SCs have been shown to decrease inflammation and enhance renal regeneration. The administration of ex vivo expanded bone marrow-derived mesenchymal SCs have been proved to be beneficial in various experimental models of acute renal failure. The mechanisms underlining this beneficial effect are still a matter of debate. Thus, therapeutic strategies aimed at correcting the regenerative potential of stem cells based on the administration of ex vivo expanded SCs or stimulating expansion and differentiation of local progenitor/SC populations are another exciting area of future research.

Phenotypic diversity and metabolic specialization of renal endothelial cells

Single-Cell RNA Sequencing Reveals Renal Endothelium Heterogeneity and Metabolic Adaptation to Water Deprivation.

Molecular Determinants of Nephron Vascular Specialization in the Kidney.

Kidney development at a glance: metabolic regulation of renal progenitor cells

Insights into Kidney Function and Disease

Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease

Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression

Glycolysis in Peritubular Endothelial Cells and Microvascular Rarefaction in CKD

Implication for Kidney Diseases

Integrated Single-Cell Transcriptomic Atlas of Human Kidney Endothelial Cells

A Systems Nephrology Approach to Diabetic Kidney Disease Research and Practice

Single-Cell Transcriptional Landscape Reveals the Regulatory Network and Its Heterogeneity of Renal Mitochondrial Damages in Diabetic Kidney Disease

Endothelial Cell Metabolism in Vascular Functions

Spatially resolved human kidney multi-omics single cell atlas highlights the key role of the fibrotic microenvironment in kidney disease progression

A microscopic view on the renal endothelial glycocalyx

Cell-Specific Targeting of the Endothelium in the CardioRenal Syndrome

Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis

Metabolic pathways and immunometabolism in rare kidney diseases

Stem cells in kidney diseases

Metabolic Pathways Fueling the Endothelial Cell Drive

Glomerular Endothelial Cells Are The Coordinator In The Development Of Diabetic Nephropathy